DMCCB Basel Symposium 2021

The topic of this DMCCB Basel symposium has been selected by our members among several proposals aiming at reinforcing the links between chemical biology, medicinal and agro chemistry, while being of importance in drug discovery.

Confirmed Speakers:

• Kamal Azzaoui, Saverna Therapeutics, Basel, CH
  «NMR Fragment Based Screening against RNAs: Examples of Successful Hit Finding Projects»
• Michaela Frye, Deutsches Krebsforschungszentrum, Heidelberg, D
• Oliver Rausch, Storm Therapeutics, Cambridge, UK «Targeting Cancer with First-in-Class Inhibitors of the RNA m6A Methyltransferase METTL3»
• Amanda E. Hargrove, Duke University, Durham, US «Modulating the Conformation and Function of Disease-Relevant RNA with Small Molecules»
• Iris Alroy, Anima Biotech, Bernardsville, US «Targeting mRNA translation in drug discovery without "shooting the messenger"»
• Matthew Disney, Scripps Research Institute, Florida, US «Sequence-Based Design of Small Molecules Targeting RNA»

Contact:

Yves P. Auberson (Novartis)
Fides Benfatti (Syngenta)
Dennis Gillingham (University of Basel)
Nina Hartrampf (University of Zurich)
Gerhard Müller (Gotham Therapeutics)
Jean-Louis Reymond (University of Bern)
Cornelia Zumbrunn (Idorsia)